Regulation of Alström syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 731-736

  Romano, Sara ^a   Milan, Gabriella ^a   Veronese, Caterina ^a   Collin, Gayle B ^b   Marshall, Jan D ^b   Centobene, Cinzia ^a   Favaretto, Francesca ^a   Dal Pra, Chiara ^a   Scarda, Alessandro ^a   Leandri, Sonia ^a   Naggert, Jürgen K ^b   Maffei, Pietro ^a   Vettor, Roberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b JACKSON LABORATORY   (United States)

Author keywords

3T3 Li; Adipogenesis; Alms1; Alstr m syndrome; Insulin sensitivity

Indexed keywords

ALSTROM SYNDROME PROTEIN 1; CELL PROTEIN; DEOXYGLUCOSE; INSULIN; MESSENGER RNA; ROSIGLITAZONE; TRITIUM; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ALMS1 PROTEIN, HUMAN; GLUCOSE; PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ALSTROM SYNDROME; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSCRIPTION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROADIPOCYTE; QUANTITATIVE ANALYSIS; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; MICE; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC;

EID: 47649118883     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.731     Document Type: Article

References (30)

1. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK and Nishina PM: New Alström syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165: 675-683, 2005.
2. Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM and Naggert JK: Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31: 74-78, 2002.
3. Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M and Wilson DI: Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 31: 79-83, 2002.
4. Collin GB, Cyr E, Bronson R, Marshall JD, Gifford EJ, Hicks W, Murray SA, Zheng QY, Smith RS, Nishina PM and Naggert JK: Alms1-disrupted mice recapitulate human Alström syndrome. Hum Mol Genet 14: 2323-2333, 2005.
5. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA and Mann M: Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574, 2003.
6. Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA and Wilson DI: Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54: 1581-1587, 2005.
7. Badano JL, Mitsuma N, Beales PL and Katsanis N: The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 22: 125-148, 2006.
8. Blacque OE and Leroux MR: Bardet-Biedl syndrome: an emerging pathomechanism of intracellular transport. Cell Mol Life Sci 63: 2145-2161, 2006.
9. Forti E, Aksanov O and Birk RZ: Temporal expression pattern of Bardet-Biedl syndrome genes in adipogenesis. Int J Biochem Cell Biol 39: 1055-1062, 2007.
10. Arsov T, Silva DG, O'Bryan MK, Sainsbury A, Lee NJ, Kennedy C, Manji SS, Nelms K, Liu C, Vinuesa CG, De Kretser DM, Goodnow CC and Petrovsky N: Fat aussie - a new Alström syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol 20: 1610-1622, 2006.
11. Li G, Vega R, Nelms K, Gekakis N, Goodnow C, McNamara P, Wu H, Hong NA and Glynne R: A role for Alström syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 3: e8, 2007.
12. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF and Flier JS: Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422, 1997.
13. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, et al: 1-Phos-phatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 91: 7415-7419, 1994.
14. Watson RT, Kanzaki M and Pessin JE: Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25: 177-204, 2004.
15. Mulder AH, Tack CJ, Olthaar AJ, Smits P, Sweep FC and Bosch RR: Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab 289: E627-E633, 2005.
16. Yu C, Cresswell J, Loffler MG and Bogan JS: The glucose transporter 4-regulating protein TUG is essential for highly insulin-responsive glucose uptake in 3T3-L1 adipocytes. J Biol Chem 282: 7710-7722, 2007.
17. Liu LB, Omata W, Kojima I and Shibata H: Insulin recruits GLUT4 from distinct compartments via distinct traffic pathways with differential microtubule dependence in rat adipocytes. J Biol Chem 278: 30157-30169, 2003.
18. Pacenti M, Barzon L, Favaretto F, Fincati K, Romano S, Milan G, Vettor R and Palu G: Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs. AIDS 20: 1691-1705, 2006.
19. Tontonoz P, Hu E and Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156, 1994.
20. Fasshauer M, Klein J, Neumann S, Eszlinger M and Paschke R: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290: 1084-1089, 2002.
21. Haugen F, Jorgensen A, Drevon CA and Trayhurn P: Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett 507: 105-108, 2001.
22. Bornens M: Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 14: 25-34, 2002.
23. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P and Baron AD: Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101: 2377-2386, 1998.
24. Debril MB, Renaud JP, Fajas L and Auwerx J: The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 79: 30-47, 2001.
25. Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE and Paterniti JR Jr: A selective peroxisome proliferator-activated receptor-gamma (PPAR-gamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 14: 1425-1433, 2000.
26. Picard F and Auwerx J: PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 22: 167-197, 2002.
27. Tamori Y, Masugi J, Nishino N and Kasuga M: Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 51: 2045-2055, 2002.
28. Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T, Verma IM and Olefsky JM: Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293: E219-E227, 2007.
29. Pryor PR, Liu SC, Clark AE, Yang J, Holman GD and Tosh D: Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J 348: 83-91, 2000.
30. Ricort JM, Tanti JF, Van Obberghen E and Le Marchand-Brustel Y: Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38: 1148-1156, 1995.